Aurobindo Pharma Limited (NSE:AUROPHARMA)
India · Delayed Price · Currency is INR 1,120.20
+6.10 (0.55%)
Jul 25, 2025, 3:30 PM IST
Aurobindo Pharma Market Cap
Aurobindo Pharma has a market cap or net worth of 647.07 billion as of July 25, 2025. Its market cap has decreased by -15.40% in one year.
Market Cap
647.07B
Enterprise Value
647.28B
Revenue
317.24B
Ranking
n/a
PE Ratio
18.63
Stock Price
1,120.20
Market Cap Chart
Since July 1, 2002, Aurobindo Pharma's market cap has increased from 9.60B to 647.07B, an increase of 6,638.03%. That is a compound annual growth rate of 20.01%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,060.39B |
| Divi's Laboratories | 1,775.45B |
| Cipla | 1,182.87B |
| Mankind Pharma | 1,102.19B |
| Apollo Hospitals Enterprise | 1,041.94B |
| Zydus Lifesciences | 976.05B |
| Glenmark Pharmaceuticals | 616.55B |
| Fortis Healthcare | 610.84B |